Elevated endothelial dysfunction-related biomarker levels indicate the severity and predict sepsis incidence

This study was conducted to investigate the relationship between serum endothelial dysfunction-related biomarker levels and organ dysfunction severity in septic patients and the predictive value of these levels during sepsis. In total, 105 patients admitted to the Department of Critical Care Medicin...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 12; no. 1; pp. 21935 - 9
Main Authors Zhou, Gaosheng, Liu, Jingjing, Zhang, Hongmin, Wang, Xiaoting, Liu, Dawei
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 19.12.2022
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This study was conducted to investigate the relationship between serum endothelial dysfunction-related biomarker levels and organ dysfunction severity in septic patients and the predictive value of these levels during sepsis. In total, 105 patients admitted to the Department of Critical Care Medicine were enrolled between September 2020 and November 2021. Serum syndecan-1 and soluble thrombomodulin(sTM) levels were measured by enzyme-linked immunosorbent assay, and clinical and laboratory data were recorded. Enroll patients were divided into the infection (n = 28), septic nonshock (n = 31), and septic shock (n = 46) groups . Serum syndecan-1 (102.84 ± 16.53 vs. 55.38 ± 12.34 ng/ml), and sTM(6.60 ± 1.44 ng/ml vs. 5.23 ± 1.23 ng/ml, P < 0.01) levels were increased in the septic group compared with those in the infection group. Serum syndecan-1 levels were closely positively correlated with serum sTM (r s  = 0.712, r 2  = 0.507, P < 0.001). Additionally, serum syndecan-1(r s  = 0.687, r 2  = 0.472, P < 0.001) and sTM levels (r s  = 0.6, r 2  = 0.36, P < 0.01) levels were significantly positively correlated with the sequential organ failure assessment scores respectively. Syndecan-1 (AUC 0.95 ± 0.02, P < 0.0001) was more valuable for prediction sepsis than was sTM (AUC 0.87 ± 0.04, P < 0.0001). Compared with sTM (AUC 0.88 ± 0.03, P < 0.001), syndecan-1 (AUC 0.95 ± 0.02, P < 0.001) and SOFA score (AUC 0.95 ± 0.02, P < 0.001) were better predictors of septic shock. Serum syndecan-1 and sTM levels were associated with organ dysfunction severity in septic patients, and both were good predictors for early identification of sepsis, particularly in patients undergoing septic shock.
AbstractList This study was conducted to investigate the relationship between serum endothelial dysfunction-related biomarker levels and organ dysfunction severity in septic patients and the predictive value of these levels during sepsis. In total, 105 patients admitted to the Department of Critical Care Medicine were enrolled between September 2020 and November 2021. Serum syndecan-1 and soluble thrombomodulin(sTM) levels were measured by enzyme-linked immunosorbent assay, and clinical and laboratory data were recorded. Enroll patients were divided into the infection (n = 28), septic nonshock (n = 31), and septic shock (n = 46) groups . Serum syndecan-1 (102.84 ± 16.53 vs. 55.38 ± 12.34 ng/ml), and sTM(6.60 ± 1.44 ng/ml vs. 5.23 ± 1.23 ng/ml, P < 0.01) levels were increased in the septic group compared with those in the infection group. Serum syndecan-1 levels were closely positively correlated with serum sTM (r  = 0.712, r  = 0.507, P < 0.001). Additionally, serum syndecan-1(r  = 0.687, r  = 0.472, P < 0.001) and sTM levels (r  = 0.6, r  = 0.36, P < 0.01) levels were significantly positively correlated with the sequential organ failure assessment scores respectively. Syndecan-1 (AUC 0.95 ± 0.02, P < 0.0001) was more valuable for prediction sepsis than was sTM (AUC 0.87 ± 0.04, P < 0.0001). Compared with sTM (AUC 0.88 ± 0.03, P < 0.001), syndecan-1 (AUC 0.95 ± 0.02, P < 0.001) and SOFA score (AUC 0.95 ± 0.02, P < 0.001) were better predictors of septic shock. Serum syndecan-1 and sTM levels were associated with organ dysfunction severity in septic patients, and both were good predictors for early identification of sepsis, particularly in patients undergoing septic shock.
This study was conducted to investigate the relationship between serum endothelial dysfunction-related biomarker levels and organ dysfunction severity in septic patients and the predictive value of these levels during sepsis. In total, 105 patients admitted to the Department of Critical Care Medicine were enrolled between September 2020 and November 2021. Serum syndecan-1 and soluble thrombomodulin(sTM) levels were measured by enzyme-linked immunosorbent assay, and clinical and laboratory data were recorded. Enroll patients were divided into the infection (n = 28), septic nonshock (n = 31), and septic shock (n = 46) groups . Serum syndecan-1 (102.84 ± 16.53 vs. 55.38 ± 12.34 ng/ml), and sTM(6.60 ± 1.44 ng/ml vs. 5.23 ± 1.23 ng/ml, P < 0.01) levels were increased in the septic group compared with those in the infection group. Serum syndecan-1 levels were closely positively correlated with serum sTM (r s  = 0.712, r 2  = 0.507, P < 0.001). Additionally, serum syndecan-1(r s  = 0.687, r 2  = 0.472, P < 0.001) and sTM levels (r s  = 0.6, r 2  = 0.36, P < 0.01) levels were significantly positively correlated with the sequential organ failure assessment scores respectively. Syndecan-1 (AUC 0.95 ± 0.02, P < 0.0001) was more valuable for prediction sepsis than was sTM (AUC 0.87 ± 0.04, P < 0.0001). Compared with sTM (AUC 0.88 ± 0.03, P < 0.001), syndecan-1 (AUC 0.95 ± 0.02, P < 0.001) and SOFA score (AUC 0.95 ± 0.02, P < 0.001) were better predictors of septic shock. Serum syndecan-1 and sTM levels were associated with organ dysfunction severity in septic patients, and both were good predictors for early identification of sepsis, particularly in patients undergoing septic shock.
This study was conducted to investigate the relationship between serum endothelial dysfunction-related biomarker levels and organ dysfunction severity in septic patients and the predictive value of these levels during sepsis. In total, 105 patients admitted to the Department of Critical Care Medicine were enrolled between September 2020 and November 2021. Serum syndecan-1 and soluble thrombomodulin(sTM) levels were measured by enzyme-linked immunosorbent assay, and clinical and laboratory data were recorded. Enroll patients were divided into the infection (n = 28), septic nonshock (n = 31), and septic shock (n = 46) groups . Serum syndecan-1 (102.84 ± 16.53 vs. 55.38 ± 12.34 ng/ml), and sTM(6.60 ± 1.44 ng/ml vs. 5.23 ± 1.23 ng/ml, P < 0.01) levels were increased in the septic group compared with those in the infection group. Serum syndecan-1 levels were closely positively correlated with serum sTM (rs = 0.712, r2 = 0.507, P < 0.001). Additionally, serum syndecan-1(rs = 0.687, r2 = 0.472, P < 0.001) and sTM levels (rs = 0.6, r2 = 0.36, P < 0.01) levels were significantly positively correlated with the sequential organ failure assessment scores respectively. Syndecan-1 (AUC 0.95 ± 0.02, P < 0.0001) was more valuable for prediction sepsis than was sTM (AUC 0.87 ± 0.04, P < 0.0001). Compared with sTM (AUC 0.88 ± 0.03, P < 0.001), syndecan-1 (AUC 0.95 ± 0.02, P < 0.001) and SOFA score (AUC 0.95 ± 0.02, P < 0.001) were better predictors of septic shock. Serum syndecan-1 and sTM levels were associated with organ dysfunction severity in septic patients, and both were good predictors for early identification of sepsis, particularly in patients undergoing septic shock.This study was conducted to investigate the relationship between serum endothelial dysfunction-related biomarker levels and organ dysfunction severity in septic patients and the predictive value of these levels during sepsis. In total, 105 patients admitted to the Department of Critical Care Medicine were enrolled between September 2020 and November 2021. Serum syndecan-1 and soluble thrombomodulin(sTM) levels were measured by enzyme-linked immunosorbent assay, and clinical and laboratory data were recorded. Enroll patients were divided into the infection (n = 28), septic nonshock (n = 31), and septic shock (n = 46) groups . Serum syndecan-1 (102.84 ± 16.53 vs. 55.38 ± 12.34 ng/ml), and sTM(6.60 ± 1.44 ng/ml vs. 5.23 ± 1.23 ng/ml, P < 0.01) levels were increased in the septic group compared with those in the infection group. Serum syndecan-1 levels were closely positively correlated with serum sTM (rs = 0.712, r2 = 0.507, P < 0.001). Additionally, serum syndecan-1(rs = 0.687, r2 = 0.472, P < 0.001) and sTM levels (rs = 0.6, r2 = 0.36, P < 0.01) levels were significantly positively correlated with the sequential organ failure assessment scores respectively. Syndecan-1 (AUC 0.95 ± 0.02, P < 0.0001) was more valuable for prediction sepsis than was sTM (AUC 0.87 ± 0.04, P < 0.0001). Compared with sTM (AUC 0.88 ± 0.03, P < 0.001), syndecan-1 (AUC 0.95 ± 0.02, P < 0.001) and SOFA score (AUC 0.95 ± 0.02, P < 0.001) were better predictors of septic shock. Serum syndecan-1 and sTM levels were associated with organ dysfunction severity in septic patients, and both were good predictors for early identification of sepsis, particularly in patients undergoing septic shock.
Abstract This study was conducted to investigate the relationship between serum endothelial dysfunction-related biomarker levels and organ dysfunction severity in septic patients and the predictive value of these levels during sepsis. In total, 105 patients admitted to the Department of Critical Care Medicine were enrolled between September 2020 and November 2021. Serum syndecan-1 and soluble thrombomodulin(sTM) levels were measured by enzyme-linked immunosorbent assay, and clinical and laboratory data were recorded. Enroll patients were divided into the infection (n = 28), septic nonshock (n = 31), and septic shock (n = 46) groups . Serum syndecan-1 (102.84 ± 16.53 vs. 55.38 ± 12.34 ng/ml), and sTM(6.60 ± 1.44 ng/ml vs. 5.23 ± 1.23 ng/ml, P < 0.01) levels were increased in the septic group compared with those in the infection group. Serum syndecan-1 levels were closely positively correlated with serum sTM (rs = 0.712, r2 = 0.507, P < 0.001). Additionally, serum syndecan-1(rs = 0.687, r2 = 0.472, P < 0.001) and sTM levels (rs = 0.6, r2 = 0.36, P < 0.01) levels were significantly positively correlated with the sequential organ failure assessment scores respectively. Syndecan-1 (AUC 0.95 ± 0.02, P < 0.0001) was more valuable for prediction sepsis than was sTM (AUC 0.87 ± 0.04, P < 0.0001). Compared with sTM (AUC 0.88 ± 0.03, P < 0.001), syndecan-1 (AUC 0.95 ± 0.02, P < 0.001) and SOFA score (AUC 0.95 ± 0.02, P < 0.001) were better predictors of septic shock. Serum syndecan-1 and sTM levels were associated with organ dysfunction severity in septic patients, and both were good predictors for early identification of sepsis, particularly in patients undergoing septic shock.
ArticleNumber 21935
Author Zhou, Gaosheng
Liu, Dawei
Liu, Jingjing
Zhang, Hongmin
Wang, Xiaoting
Author_xml – sequence: 1
  givenname: Gaosheng
  surname: Zhou
  fullname: Zhou, Gaosheng
  organization: Department of Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
– sequence: 2
  givenname: Jingjing
  surname: Liu
  fullname: Liu, Jingjing
  organization: Department of Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
– sequence: 3
  givenname: Hongmin
  surname: Zhang
  fullname: Zhang, Hongmin
  organization: Department of Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
– sequence: 4
  givenname: Xiaoting
  surname: Wang
  fullname: Wang, Xiaoting
  organization: Department of Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
– sequence: 5
  givenname: Dawei
  surname: Liu
  fullname: Liu, Dawei
  email: dwliu2016@126.com
  organization: Department of Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36536028$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1v1DAQtVARLaV_gAPKkUsgtmPHuSChqkClSlzgbDmeydaL117spFL-fb2bFrUc6outeR8z8ry35CTEgIS8p80n2nD1ObdU9KpuGKuZlIzXyytyxppW1IwzdvLkfUouct425QjWt7R_Q065FFw2TJ0Rf-XxzkwIFQaI0y16Z3wFSx7nYCcXQ53QH_HBxZ1JfzBVRYE-Vy6AswWqiqrKpZbctFQmQLVPWKCpFPfZHYjWAQaL78jr0fiMFw_3Ofn97erX5Y_65uf368uvN7UVlE01dtjBwA2zIA0flFFgmbQUut4CMGh7wN7IYWwtZ1JJPrZ0QGMGaEUrOOfn5Hr1hWi2ep9cGXzR0Th9LMS00SZNznrUioKwDe8tByw_KgzQbqBKdUMjRoFt8fqyeu3nYYdgMUzJ-Gemz5HgbvUm3um-k5wzUQw-Phik-HfGPOmdyxa9NwHjnDXrhKSMql4V6oenvf41eVxXIaiVYFPMOeGorZvMYU2ltfOaNvoQDr2GQ5dw6GM49FKk7D_po_uLIr6KciGHDSa9jXMKZXcvqe4BeFHQtw
CitedBy_id crossref_primary_10_1016_j_ijbiomac_2025_139548
crossref_primary_10_1080_1744666X_2024_2366301
crossref_primary_10_1002_pgr2_70011
crossref_primary_10_3390_jcm12134386
crossref_primary_10_1038_s41598_024_71670_2
crossref_primary_10_3233_CH_242157
crossref_primary_10_2174_0113894501250057231102061624
crossref_primary_10_3389_fmed_2023_1252021
crossref_primary_10_1093_trstmh_trad077
crossref_primary_10_1177_03913988251315092
crossref_primary_10_1007_s00068_023_02369_8
crossref_primary_10_3389_fmed_2024_1496869
Cites_doi 10.1055/s-0034-1398377
10.1186/s13054-015-0918-5
10.1186/s13054-017-1605-5
10.1016/j.ajem.2021.01.019
10.1186/s13054-018-2292-6
10.1016/j.ajpath.2019.11.016
10.1111/j.1399-6576.2011.02578.x
10.1164/rccm.201910-1911TR
10.1111/liv.13087
10.1186/s12916-015-0365-9
10.1016/j.jcrc.2017.07.049
10.1016/j.clinbiochem.2016.02.014
10.1001/jama.2016.0287
10.21037/apm-21-1048
10.1097/SHK.0b013e318157e926
10.1186/s13054-021-03545-1
10.1038/s41598-022-14365-w
10.1089/ars.2021.0027
10.1177/0885066620949131
10.3389/fimmu.2019.02535
10.1097/TA.0b013e31821e0f93
10.1016/j.ymgme.2012.01.016
10.1097/SHK.0000000000000473
10.1186/cc12532
10.1097/CCM.0b013e3181c98d21
10.1016/j.jcrc.2018.06.015
10.1016/j.ccc.2019.12.001
10.1097/SHK.0b013e3181777da3
10.1055/s-0038-1648199
ContentType Journal Article
Copyright The Author(s) 2022
2022. The Author(s).
Copyright_xml – notice: The Author(s) 2022
– notice: 2022. The Author(s).
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1038/s41598-022-26623-y
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic
CrossRef

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 9
ExternalDocumentID oai_doaj_org_article_81d5c039c3de4155ad17b1887b05f5e4
PMC9763325
36536028
10_1038_s41598_022_26623_y
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7X8
PPXIY
PQGLB
5PM
PJZUB
PUEGO
ID FETCH-LOGICAL-c512t-e7e7db3a2cd6a3b8a8dc26c1d79cdd2d49de9a6bf4c326863f41beaabd4545333
IEDL.DBID DOA
ISSN 2045-2322
IngestDate Wed Aug 27 01:31:50 EDT 2025
Thu Aug 21 18:38:57 EDT 2025
Fri Jul 11 09:43:07 EDT 2025
Thu Jan 02 22:52:44 EST 2025
Thu Apr 24 23:01:40 EDT 2025
Tue Jul 01 00:55:38 EDT 2025
Fri Feb 21 02:39:03 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2022. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c512t-e7e7db3a2cd6a3b8a8dc26c1d79cdd2d49de9a6bf4c326863f41beaabd4545333
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/81d5c039c3de4155ad17b1887b05f5e4
PMID 36536028
PQID 2756121898
PQPubID 23479
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_81d5c039c3de4155ad17b1887b05f5e4
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9763325
proquest_miscellaneous_2756121898
pubmed_primary_36536028
crossref_citationtrail_10_1038_s41598_022_26623_y
crossref_primary_10_1038_s41598_022_26623_y
springer_journals_10_1038_s41598_022_26623_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-12-19
PublicationDateYYYYMMDD 2022-12-19
PublicationDate_xml – month: 12
  year: 2022
  text: 2022-12-19
  day: 19
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2022
Publisher Nature Publishing Group UK
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Portfolio
References Johansson, Stensballe, Rasmussen, Ostrowski (CR14) 2012; 72
Dogné, Flamion (CR5) 2020; 190
Liu, Zhou, Chen, Tong, Zhang, Wang, Liu (CR29) 2022; 12
Ishii, Uchiyama, Kazama (CR12) 1991; 65
Levi, van der Poll (CR25) 2010; 38
Saoraya, Wongsamita, Srisawat, Musikatavorn (CR22) 2021; 42
Smart, Bosio, Macdonald (CR7) 2018; 47
Piotti, Novelli, Meessen (CR20) 2021; 25
Huang, Hu, Sun (CR21) 2021; 36
La Mura, Tripodi, Tosetti (CR10) 2016; 36
Ostrowski, Pedersen, Jensen, Mogelvang, Johansson (CR15) 2013; 17
Ikeda, Matsumoto, Ogura (CR6) 2018; 43
Yue, Deng, Yang, Li (CR19) 2021; 10
Ostrowski, Haase, Müller, Møller, Pott, Perner, Johansson (CR23) 2015; 19
Nelson, Berkestedt, Schmidtchen, Ljunggren, Bodelsson (CR8) 2008; 30
Joffre, Hellman, Ince, Ait-Oufella (CR3) 2020; 202
El-Hattab, Hsu, Emrick (CR27) 2012; 105
Pons, Arnaud, Loiselle, Arrii, Azoulay, Zafrani (CR16) 2020; 36
Shrestha, Ito, Kakuuchi (CR11) 2019; 10
Ince, Mayeux, Nguyen (CR2) 2016; 45
Marechal, Favory, Joulin (CR13) 2008; 29
Singer, Deutschman, Seymour (CR1) 2016; 315
Anand, Ray, Srivastava, Bhargava (CR18) 2016; 49
Johansen, Johansson, Ostrowski (CR17) 2015; 41
Joffre, Hellman (CR26) 2021; 35
Sallisalmi, Tenhunen, Yang, Oksala, Pettilä (CR9) 2012; 56
Uchimido, Schmidt, Shapiro (CR4) 2019; 23
Hanson, Lee, Hossain (CR28) 2015; 13
Johansson, Stensballe, Ostrowski (CR24) 2017; 21
L Smart (26623_CR7) 2018; 47
M Levi (26623_CR25) 2010; 38
M Singer (26623_CR1) 2016; 315
PI Johansson (26623_CR24) 2017; 21
J Joffre (26623_CR26) 2021; 35
D Anand (26623_CR18) 2016; 49
AW El-Hattab (26623_CR27) 2012; 105
X Huang (26623_CR21) 2021; 36
B Shrestha (26623_CR11) 2019; 10
PI Johansson (26623_CR14) 2012; 72
J Hanson (26623_CR28) 2015; 13
L Yue (26623_CR19) 2021; 10
A Piotti (26623_CR20) 2021; 25
R Uchimido (26623_CR4) 2019; 23
J Joffre (26623_CR3) 2020; 202
H Ishii (26623_CR12) 1991; 65
SR Ostrowski (26623_CR15) 2013; 17
A Nelson (26623_CR8) 2008; 30
SR Ostrowski (26623_CR23) 2015; 19
S Dogné (26623_CR5) 2020; 190
X Marechal (26623_CR13) 2008; 29
S Pons (26623_CR16) 2020; 36
ME Johansen (26623_CR17) 2015; 41
J Saoraya (26623_CR22) 2021; 42
M Ikeda (26623_CR6) 2018; 43
V La Mura (26623_CR10) 2016; 36
J Liu (26623_CR29) 2022; 12
M Sallisalmi (26623_CR9) 2012; 56
C Ince (26623_CR2) 2016; 45
References_xml – volume: 41
  start-page: 16
  issue: 1
  year: 2015
  end-page: 25
  ident: CR17
  article-title: Profound endothelial damage predicts impending organ failure and death in sepsis
  publication-title: Semin. Thromb. Hemost.
  doi: 10.1055/s-0034-1398377
– volume: 19
  start-page: 191
  year: 2015
  ident: CR23
  article-title: Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: A prospective study
  publication-title: Crit. Care
  doi: 10.1186/s13054-015-0918-5
– volume: 21
  start-page: 25
  year: 2017
  ident: CR24
  article-title: Shock induced endotheliopathy (SHINE) in acute critical illness: A unifying pathophysiologic mechanism
  publication-title: Crit. Care
  doi: 10.1186/s13054-017-1605-5
– volume: 42
  start-page: 83
  year: 2021
  end-page: 89
  ident: CR22
  article-title: Plasma syndecan-1 is associated with fluid requirements and clinical outcomes in emergency department patients with sepsis
  publication-title: Am. J. Emerg. Med.
  doi: 10.1016/j.ajem.2021.01.019
– volume: 23
  start-page: 16
  issue: 1
  year: 2019
  ident: CR4
  article-title: The glycocalyx: A novel diagnostic and therapeutic target in sepsis
  publication-title: Crit. Care
  doi: 10.1186/s13054-018-2292-6
– volume: 190
  start-page: 768
  issue: 4
  year: 2020
  end-page: 780
  ident: CR5
  article-title: Endothelial glycocalyx impairment in disease: Focus on hyaluronan shedding
  publication-title: Am. J. Pathol.
  doi: 10.1016/j.ajpath.2019.11.016
– volume: 56
  start-page: 316
  issue: 3
  year: 2012
  end-page: 322
  ident: CR9
  article-title: Vascular adhesion protein-1 and syndecan-1 in septic shock
  publication-title: Acta Anaesthesiol. Scand.
  doi: 10.1111/j.1399-6576.2011.02578.x
– volume: 202
  start-page: 361
  issue: 3
  year: 2020
  end-page: 370
  ident: CR3
  article-title: Endothelial responses in sepsis
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.201910-1911TR
– volume: 36
  start-page: 1322
  issue: 9
  year: 2016
  end-page: 1330
  ident: CR10
  article-title: Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis
  publication-title: Liver Int.
  doi: 10.1111/liv.13087
– volume: 13
  start-page: 122
  year: 2015
  ident: CR28
  article-title: Microvascular obstruction and endothelial activation are independently associated with the clinical manifestations of severe falciparum malaria in adults: An observational study
  publication-title: BMC Med.
  doi: 10.1186/s12916-015-0365-9
– volume: 43
  start-page: 48
  year: 2018
  end-page: 53
  ident: CR6
  article-title: Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis
  publication-title: J. Crit. Care
  doi: 10.1016/j.jcrc.2017.07.049
– volume: 49
  start-page: 768
  issue: 10–11
  year: 2016
  end-page: 776
  ident: CR18
  article-title: Evolution of serum hyaluronan and syndecan levels in prognosis of sepsis patients
  publication-title: Clin. Biochem.
  doi: 10.1016/j.clinbiochem.2016.02.014
– volume: 315
  start-page: 801
  issue: 8
  year: 2016
  end-page: 810
  ident: CR1
  article-title: The third international consensus definitions for sepsis and septic shock (Sepsis-3)
  publication-title: JAMA
  doi: 10.1001/jama.2016.0287
– volume: 10
  start-page: 5561
  issue: 5
  year: 2021
  end-page: 5567
  ident: CR19
  article-title: Elevated B-type natriuretic peptide (BNP) and soluble thrombomodulin (sTM) indicates severity and poor prognosis of sepsis
  publication-title: Ann. Palliat. Med.
  doi: 10.21037/apm-21-1048
– volume: 29
  start-page: 572
  issue: 5
  year: 2008
  end-page: 576
  ident: CR13
  article-title: Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress
  publication-title: Shock
  doi: 10.1097/SHK.0b013e318157e926
– volume: 25
  start-page: 113
  issue: 1
  year: 2021
  ident: CR20
  article-title: Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: A substudy of ALBIOS
  publication-title: Crit. Care
  doi: 10.1186/s13054-021-03545-1
– volume: 12
  start-page: 10414
  year: 2022
  ident: CR29
  article-title: Mitochondrial Sirt3 serves as a biomarker for sepsis diagnosis and mortality prediction
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-022-14365-w
– volume: 35
  start-page: 1291
  year: 2021
  end-page: 1307
  ident: CR26
  article-title: Oxidative stress and endothelial dysfunction in sepsis and acute inflammation
  publication-title: Antioxid. Redox Signal.
  doi: 10.1089/ars.2021.0027
– volume: 36
  start-page: 1286
  issue: 11
  year: 2021
  end-page: 1295
  ident: CR21
  article-title: Plasma endothelial glycocalyx components as a potential biomarker for predicting the development of disseminated intravascular coagulation in patients with sepsis
  publication-title: J. Intensive Care Med.
  doi: 10.1177/0885066620949131
– volume: 10
  start-page: 2535
  year: 2019
  ident: CR11
  article-title: Recombinant thrombomodulin suppresses histone-induced neutrophil extracellular trap formation
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.02535
– volume: 72
  start-page: 428
  issue: 2
  year: 2012
  end-page: 436
  ident: CR14
  article-title: High circulating adrenaline levels at admission predict increased mortality after trauma
  publication-title: J. Trauma Acute Care Surg.
  doi: 10.1097/TA.0b013e31821e0f93
– volume: 105
  start-page: 607
  issue: 4
  year: 2012
  end-page: 614
  ident: CR27
  article-title: Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation
  publication-title: Mol. Genet. Metab.
  doi: 10.1016/j.ymgme.2012.01.016
– volume: 45
  start-page: 259
  issue: 3
  year: 2016
  end-page: 270
  ident: CR2
  article-title: The endothelium in sepsis
  publication-title: Shock
  doi: 10.1097/SHK.0000000000000473
– volume: 17
  start-page: R32
  issue: 1
  year: 2013
  ident: CR15
  article-title: Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines
  publication-title: Crit. Care
  doi: 10.1186/cc12532
– volume: 38
  start-page: S26
  issue: 2 Suppl
  year: 2010
  end-page: 34
  ident: CR25
  article-title: Inflammation and coagulation
  publication-title: Crit. Care Med.
  doi: 10.1097/CCM.0b013e3181c98d21
– volume: 47
  start-page: 93
  year: 2018
  end-page: 98
  ident: CR7
  article-title: Glycocalyx biomarker syndecan-1 is a stronger predictor of respiratory failure in patients with sepsis due to pneumonia, compared to endocan
  publication-title: J. Crit. Care
  doi: 10.1016/j.jcrc.2018.06.015
– volume: 36
  start-page: 401
  issue: 2
  year: 2020
  end-page: 413
  ident: CR16
  article-title: Immune consequences of endothelial cells' activation and dysfunction during sepsis
  publication-title: Crit. Care Clin.
  doi: 10.1016/j.ccc.2019.12.001
– volume: 30
  start-page: 623
  issue: 6
  year: 2008
  end-page: 627
  ident: CR8
  article-title: Increased levels of glycosaminoglycans during septic shock: Relation to mortality and the antibacterial actions of plasma
  publication-title: Shock
  doi: 10.1097/SHK.0b013e3181777da3
– volume: 65
  start-page: 618
  issue: 5
  year: 1991
  end-page: 623
  ident: CR12
  article-title: Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells
  publication-title: Thromb. Haemost.
  doi: 10.1055/s-0038-1648199
– volume: 202
  start-page: 361
  issue: 3
  year: 2020
  ident: 26623_CR3
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.201910-1911TR
– volume: 72
  start-page: 428
  issue: 2
  year: 2012
  ident: 26623_CR14
  publication-title: J. Trauma Acute Care Surg.
  doi: 10.1097/TA.0b013e31821e0f93
– volume: 10
  start-page: 2535
  year: 2019
  ident: 26623_CR11
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.02535
– volume: 23
  start-page: 16
  issue: 1
  year: 2019
  ident: 26623_CR4
  publication-title: Crit. Care
  doi: 10.1186/s13054-018-2292-6
– volume: 36
  start-page: 1286
  issue: 11
  year: 2021
  ident: 26623_CR21
  publication-title: J. Intensive Care Med.
  doi: 10.1177/0885066620949131
– volume: 25
  start-page: 113
  issue: 1
  year: 2021
  ident: 26623_CR20
  publication-title: Crit. Care
  doi: 10.1186/s13054-021-03545-1
– volume: 45
  start-page: 259
  issue: 3
  year: 2016
  ident: 26623_CR2
  publication-title: Shock
  doi: 10.1097/SHK.0000000000000473
– volume: 36
  start-page: 1322
  issue: 9
  year: 2016
  ident: 26623_CR10
  publication-title: Liver Int.
  doi: 10.1111/liv.13087
– volume: 42
  start-page: 83
  year: 2021
  ident: 26623_CR22
  publication-title: Am. J. Emerg. Med.
  doi: 10.1016/j.ajem.2021.01.019
– volume: 19
  start-page: 191
  year: 2015
  ident: 26623_CR23
  publication-title: Crit. Care
  doi: 10.1186/s13054-015-0918-5
– volume: 315
  start-page: 801
  issue: 8
  year: 2016
  ident: 26623_CR1
  publication-title: JAMA
  doi: 10.1001/jama.2016.0287
– volume: 36
  start-page: 401
  issue: 2
  year: 2020
  ident: 26623_CR16
  publication-title: Crit. Care Clin.
  doi: 10.1016/j.ccc.2019.12.001
– volume: 190
  start-page: 768
  issue: 4
  year: 2020
  ident: 26623_CR5
  publication-title: Am. J. Pathol.
  doi: 10.1016/j.ajpath.2019.11.016
– volume: 29
  start-page: 572
  issue: 5
  year: 2008
  ident: 26623_CR13
  publication-title: Shock
  doi: 10.1097/SHK.0b013e318157e926
– volume: 35
  start-page: 1291
  year: 2021
  ident: 26623_CR26
  publication-title: Antioxid. Redox Signal.
  doi: 10.1089/ars.2021.0027
– volume: 49
  start-page: 768
  issue: 10–11
  year: 2016
  ident: 26623_CR18
  publication-title: Clin. Biochem.
  doi: 10.1016/j.clinbiochem.2016.02.014
– volume: 38
  start-page: S26
  issue: 2 Suppl
  year: 2010
  ident: 26623_CR25
  publication-title: Crit. Care Med.
  doi: 10.1097/CCM.0b013e3181c98d21
– volume: 21
  start-page: 25
  year: 2017
  ident: 26623_CR24
  publication-title: Crit. Care
  doi: 10.1186/s13054-017-1605-5
– volume: 47
  start-page: 93
  year: 2018
  ident: 26623_CR7
  publication-title: J. Crit. Care
  doi: 10.1016/j.jcrc.2018.06.015
– volume: 56
  start-page: 316
  issue: 3
  year: 2012
  ident: 26623_CR9
  publication-title: Acta Anaesthesiol. Scand.
  doi: 10.1111/j.1399-6576.2011.02578.x
– volume: 12
  start-page: 10414
  year: 2022
  ident: 26623_CR29
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-022-14365-w
– volume: 65
  start-page: 618
  issue: 5
  year: 1991
  ident: 26623_CR12
  publication-title: Thromb. Haemost.
  doi: 10.1055/s-0038-1648199
– volume: 105
  start-page: 607
  issue: 4
  year: 2012
  ident: 26623_CR27
  publication-title: Mol. Genet. Metab.
  doi: 10.1016/j.ymgme.2012.01.016
– volume: 13
  start-page: 122
  year: 2015
  ident: 26623_CR28
  publication-title: BMC Med.
  doi: 10.1186/s12916-015-0365-9
– volume: 41
  start-page: 16
  issue: 1
  year: 2015
  ident: 26623_CR17
  publication-title: Semin. Thromb. Hemost.
  doi: 10.1055/s-0034-1398377
– volume: 30
  start-page: 623
  issue: 6
  year: 2008
  ident: 26623_CR8
  publication-title: Shock
  doi: 10.1097/SHK.0b013e3181777da3
– volume: 17
  start-page: R32
  issue: 1
  year: 2013
  ident: 26623_CR15
  publication-title: Crit. Care
  doi: 10.1186/cc12532
– volume: 43
  start-page: 48
  year: 2018
  ident: 26623_CR6
  publication-title: J. Crit. Care
  doi: 10.1016/j.jcrc.2017.07.049
– volume: 10
  start-page: 5561
  issue: 5
  year: 2021
  ident: 26623_CR19
  publication-title: Ann. Palliat. Med.
  doi: 10.21037/apm-21-1048
SSID ssj0000529419
Score 2.4443855
Snippet This study was conducted to investigate the relationship between serum endothelial dysfunction-related biomarker levels and organ dysfunction severity in...
Abstract This study was conducted to investigate the relationship between serum endothelial dysfunction-related biomarker levels and organ dysfunction severity...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 21935
SubjectTerms 692/308
692/53
Biomarkers
Humanities and Social Sciences
Humans
Incidence
multidisciplinary
Multiple Organ Failure
Prognosis
ROC Curve
Science
Science (multidisciplinary)
Sepsis
Shock, Septic
Syndecan-1
Vascular Diseases
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA_nieDL4bfVUyL4ptVtkybNgxwqdxyCPrlwbyHJpHpQumu7J9f_3pl-LKwu9ySUPrRJPzIz-f3CZGYYey2VDCYCpFqBSaVSIfUBT4tKB5wMS2_ckO3zmzpfyi8XxcUBm8sdTQPY7V3aUT2pZVu_u_7Vn6DBfxhDxsv3HYIQBYrhsgrhJhdpf4vdRmTSZKhfJ7o_5vrOjczMFDuzv-sOPg1p_Pdxz3-3UP7lRx3g6eweO5p4Jf84KsJ9dhCbB-zOWGmyf8jq0zr-RloJPDZAQVc16h2HviNcI9mkQ1AL3qd4fNqy0_Ka9hN1nJzatG2KYy-OOBqp3B13DfB1S16eDV5cd5fUMIwVSh-x5dnp98_n6VRoIQ2I95s06qjBC5cHUE740pUQchUy0CYA5CANRJSZr2RAtlcqUcnMR-c8SCRgQojH7LBZNfEp48rnwnlRxErjQjMoLyCL-AStowBEzIRl8_DaMGUhp2IYtR284aK0o0gsisQOIrF9wt5s-6zHHBw3tv5EUtu2pPzZw4VV-8NO5miRpRdhIUwQEIlSOci0z3DC9YuiKqJM2KtZ5hbtjZworomrq85SuvwMeZEpE_Zk1IHtq4QqhELCljC9ox0737J7p7n8OeT0RlYoRF4k7O2sR3a2hRv-9dn_-Nfn7G5OBpDhYY7Z4aa9ii-QaW38y8F8_gDjCSht
  priority: 102
  providerName: Scholars Portal
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEB_OE8EXOT-vnkoE37S4bdK0edTljsMHnzy4t5BkUj0o3WW7J-x_70zaLqweB0LpQ5P0IzPN_NqZ-Q3AB6VVMBExrzWaXGkdch9ot2jrQIth441LbJ_f9eWV-nZdXR9BOefCpKD9RGmZluk5OuzzQIaGk8Ho04lMSinz3QN4yNTtrNVLvdz_V2HPlSrMlB-zkM0dQw9sUKLqvwtf_hsm-ZevNJmgixN4MmFH8WW826dwFPtn8GisJrl7Dt15F38TdEQRe-TEqo50S-BuYNvF85-nxBVq55x7DsvZiI5jhgbBjmsOjRI0SpCtjFzSTrgexXrDnpwtHVwPN9wxjFVIX8DVxfmP5WU-FVPIA9n0bR7rWKOXrgyonfSNazCUOhRYm4BYojIYSS6-VYEQXaNlqwofnfOoCGRJKV_Ccb_q4ykI7UvpvKxiy_MftJdYRDpDXUeJZBUzKObptWFiGueCF51NHm_Z2FEklkRik0jsLoOP-zHrkWfj3t5fWWr7nsyRnQ6sNj_tpDOWkHgVFtIEiZFhk8Oi9gUtqn5RtVVUGbyfZW7pnWJHievj6nawTIlfEPYxTQavRh3YX0rqSmoCZRnUB9pxcC-HLf3Nr8TbTchPyrLK4NOsR3ZaMIZ7nvX1_3U_g8clq3pBm3kDx9vNbXxLuGnr36UX5Q_qVBZ1
  priority: 102
  providerName: Springer Nature
Title Elevated endothelial dysfunction-related biomarker levels indicate the severity and predict sepsis incidence
URI https://link.springer.com/article/10.1038/s41598-022-26623-y
https://www.ncbi.nlm.nih.gov/pubmed/36536028
https://www.proquest.com/docview/2756121898
https://pubmed.ncbi.nlm.nih.gov/PMC9763325
https://doaj.org/article/81d5c039c3de4155ad17b1887b05f5e4
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9swEBdbx2AvY9_1PoIGe9tMY0uWrMc0pJTAythWyJuQdAorGDfE6SD__e5kJzTb6F4GxgZZ8tedfD9xd79j7INUMpgIkGsFJpdKhdwH3I2XOuDPsPbGJbbPC3V-KeeLanGr1BfFhPX0wP2HO0E8VYWxMEFAJOPnoNC-wKnhx9WyiokJFG3ercVUz-pdGlmYIUtmLOqTDgdTNhmuvdAmlSLfHliiRNj_N5T5Z7Dkbx7TZIjOnrDHA4Lkk_7Jn7J7sX3GHvY1JbfPWTNr4k8EkMBjC5Re1aCGcdh2ZMFICnlKX8HzlHlPwTlr3lDkUMfJfU0BUhxHcbSYkQrbcdcCX63Jn7PBxlV3RR1DX4v0Bbs8m32fnudDSYU8oGXf5FFHDV64MoBywteuhlCqUIA2AaAEaSCidPxSBsR1tRJLWfjonAeJUEsI8ZIdtddtPGZc-VI4L6q41LikDMoLKCJeQesoAG1jxord57Vh4BunsheNTX5vUdteJBZFYpNI7DZjH_djVj3bxp29T0lq-57ElJ0aUH_soD_2X_qTsfc7mVucWeQucW28vuksEeMXiIBMnbFXvQ7sbyVUJRRCs4zpA-04eJbDM-3Vj8TejfhPiLLK2KedHtnht9Hd8a6v_8e7vmGPSpoABW7mLTvarG_iO8RUGz9i9_VCj9iDyWT-bY7H09nFl6_YOlXTUZpauP8s61_-bCYW
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEB_OE9EX8dv6GcE3LW6bNG0fdblj1fOe7uDeQpJJ9aB0l-2esP-9M2m7sHocCKUP-WjTzCTzS-cL4L3SytcBMS011qnS2qfO023WlJ42w8rVNkb7PNWLc_Xtorg4gHzyhYlG-zGkZdymJ-uwTz0JGnYGo6MTiZRcpttbcJuwtmYzrrme7_6rsOZKZfXoHzOT1TVd92RQDNV_Hb7810zyL11pFEHHD-D-iB3F52G0D-EgdI_gzpBNcvsY2qM2_CboiCJ0yI5VLfGWwG3PsovnP42OK1TPPvdslrMWLdsM9YIV12waJaiXIFkZOKWdsB2K1Zo1ORsqXPWX3NAPWUifwPnx0dl8kY7JFFJPMn2ThjKU6KTNPWorXWUr9Ln2GZa1R8xR1RiILq5RnhBdpWWjMhesdagIZEkpn8Jht-zCcxDa5dI6WYSmpMOk105iFugJZRkkklRMIJum1_gx0jgnvGhN1HjLygwkMUQSE0litgl82PVZDXE2bmz9ham2a8kxsmPBcv3TjDxjCIkXfiZrLzEwbLKYlS6jTdXNiqYIKoF3E80NrSlWlNguLK96wyHxM8I-dZXAs4EHdq-SupCaQFkC5R537I1lv6a7_BXjdhPykzIvEvg48ZEZN4z-hm998X_N38LdxdmPE3Py9fT7S7iXM9tndNWv4HCzvgqvCUNt3Ju4aP4AKkwZZA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEB_OE8UX8dv6GcE3rbZNmrSPut5yfnD44MG9hSaT6kHpLts9Yf97Z9LuwupxIJQ-NJM27Uwyv3S-AF4rrXwdEFOjsU6V1j51nk5ZazwthpWrm5jt80Qfn6ovZ-XZAehtLEx02o8pLeMyvfUOez-QouFgMNo6kUopZLp5t8T2GlwnvJ3xpmumZ7t_K2y9Unk9xchksrqk-54eiun6L8OY_7pK_mUvjWpofgduT_hRfBhHfBcOQn8PbowVJTf3oTvqwm-CjyhCjxxc1ZF8CdwMrL-YB2kMXqF2jrtn15yV6NhvaBBsvGb3KEG9BOnLwGXtRNOjWK7YmrOmi8vhnAn9WIn0AZzOj37MjtOpoELqSa-v02CCQSebwqNupKuaCn2hfY6m9ogFqhoD8ca1yhOqq7RsVe5C0zhUBLSklA_hsF_04TEI7QrZOFmG1tCG0msnMQ90B2OCRNKMCeTbz2v9lG2ci150Nlq9ZWVHllhiiY0ssZsE3uz6LMdcG1dSf2Su7Sg5T3a8sFj9tJPcWELjpc9k7SUGhk4N5sbltLC6rGzLoBJ4teW5pXnFxpKmD4uLwXJa_JzwT10l8GiUgd2jpC6lJmCWgNmTjr2x7Lf0579i7m5Cf1IWZQJvt3Jkp0VjuOJdn_wf-Uu4-f3T3H77fPL1KdwqWOpzOupncLheXYTnBKPW7kWcM38AD1IabQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elevated+endothelial+dysfunction-related+biomarker+levels+indicate+the+severity+and+predict+sepsis+incidence&rft.jtitle=Scientific+reports&rft.au=Gaosheng+Zhou&rft.au=Jingjing+Liu&rft.au=Hongmin+Zhang&rft.au=Xiaoting+Wang&rft.date=2022-12-19&rft.pub=Nature+Portfolio&rft.eissn=2045-2322&rft.volume=12&rft.issue=1&rft.spage=1&rft.epage=9&rft_id=info:doi/10.1038%2Fs41598-022-26623-y&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_81d5c039c3de4155ad17b1887b05f5e4
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon